Yokosuka Kimiaki, Park Jin Soo, Jimbo Kotaro, Yoshida Tatuhiro, Yamada Kei, Sato Kimiaki, Takeuchi Masayoshi, Yamagishi Sho-ichi, Nagata Kensei
Department of Orthopedic Surgery, Kurume University School of Medicine, Kurume, Japan.
Spine (Phila Pa 1976). 2007 May 15;32(11):E337-9. doi: 10.1097/01.brs.0000263417.17526.35.
This study correlates advanced glycation end products with ossified ligament tissues of the cervical spine in vitro.
To investigate the effect of advanced glycation end products on ossification of the spinal ligaments in vitro.
We have hypothesized that an accumulation of advanced glycation end products in the spinal ligament might result in some observable change in specific growth factors responsible for ossification in the spinal ligaments.
Samples of the posterior longitudinal and yellow ligaments were harvested from patients (n = 5) with ossification of the posterior longitudinal ligament, and analyzed for the presence of advanced glycation end products and their receptor advanced glycation end product receptor by immunohistochemistry. Real-time polymerase chain reaction (PCR) was used to quantify the messenger ribonucleic acid (mRNA) levels of bone morphogenetic protein (BMP)-2, BMP-7, alkaline phosphatase, an osteoblast-specific transcription factor 1 (Cbfa1), and osteocalcin from yellow ligament cells treated with advanced glycation end products.
Immunohistochemical analysis revealed that advanced glycation end products and advanced glycation end product receptor were localized to within the posterior longitudinal and yellow ligaments. Advanced glycation end products were found to increase significantly the expression of BMP-2, BMP-7, Cbfa1, and osteocalcin at the mRNA levels after treatment with advanced glycation end products (1 microg/mL).
This is the first report to investigate the correlation, if any, between the ossified spinal ligament and advanced glycation end products. These results suggested that accumulation in advanced glycation end products and their interaction with advanced glycation end product receptor were 1 of the important risk factors in the process of ossification in the spinal ligaments.
本研究在体外将晚期糖基化终末产物与颈椎的骨化韧带组织相关联。
探讨晚期糖基化终末产物对体外脊柱韧带骨化的影响。
我们推测脊柱韧带中晚期糖基化终末产物的积累可能会导致负责脊柱韧带骨化的特定生长因子发生一些可观察到的变化。
从患有后纵韧带骨化的患者(n = 5)中获取后纵韧带和黄韧带样本,通过免疫组织化学分析晚期糖基化终末产物及其受体晚期糖基化终末产物受体的存在情况。使用实时聚合酶链反应(PCR)定量用晚期糖基化终末产物处理的黄韧带细胞中骨形态发生蛋白(BMP)-2、BMP-7、碱性磷酸酶、成骨细胞特异性转录因子1(Cbfa1)和骨钙素的信使核糖核酸(mRNA)水平。
免疫组织化学分析显示,晚期糖基化终末产物和晚期糖基化终末产物受体定位于后纵韧带和黄韧带内。在用晚期糖基化终末产物(1微克/毫升)处理后,发现晚期糖基化终末产物在mRNA水平上显著增加了BMP-2、BMP-7、Cbfa1和骨钙素的表达。
这是第一份研究骨化脊柱韧带与晚期糖基化终末产物之间是否存在相关性的报告。这些结果表明,晚期糖基化终末产物的积累及其与晚期糖基化终末产物受体的相互作用是脊柱韧带骨化过程中的重要危险因素之一。